Dr. Young on the Challenges of Using Anticoagulants in Children With Cancer

Guy Young, MD
Published: Tuesday, Nov 28, 2017



Guy Young, MD, director, Hemostasis and Thrombosis Program, attending physician, Hematology, Oncology and Blood and Marrow Transplantation, Children’s Hospital Los Angeles, discusses the challenges of using anticoagulants in children with cancer.

Using anticoagulants in children with cancer is challenging because children have a higher risk of experiencing day-to-day trauma, says Young. Traumas such as a scraped knee are a normal occurrence for children, but when on an anticoagulant, the risk of bleeding is much higher.
 
SELECTED
LANGUAGE


Guy Young, MD, director, Hemostasis and Thrombosis Program, attending physician, Hematology, Oncology and Blood and Marrow Transplantation, Children’s Hospital Los Angeles, discusses the challenges of using anticoagulants in children with cancer.

Using anticoagulants in children with cancer is challenging because children have a higher risk of experiencing day-to-day trauma, says Young. Traumas such as a scraped knee are a normal occurrence for children, but when on an anticoagulant, the risk of bleeding is much higher.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Atlanta: Advances in the Treatment of Chronic Lymphocytic LeukemiaFeb 28, 20190.5
Year in Review™: Reflecting on Recent Evidence for the Treatment of Hematologic MalignanciesFeb 28, 20192.0
Publication Bottom Border
Border Publication
x